Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA; Rothman Institute, Philadelphia, PA.
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA.
J Arthroplasty. 2022 Sep;37(9):1731-1736. doi: 10.1016/j.arth.2022.04.004. Epub 2022 Apr 9.
Laboratory tests are obtained following total joint arthroplasty (TJA) despite a lack of supporting evidence. No prior study has prospectively analyzed the effect of discontinuing routine laboratory tests. This study aimed to determine whether discontinuing routine laboratory tests in TJA patients resulted in a difference in 90-day complications.
This was a prospective protocol change study at a high-volume center. Prior to protocol change, patients underwent routine laboratory tests following primary unilateral TJA (control group). After the change, an algorithmic approach was used to selectively order laboratory tests (protocol group). Patients with bleeding disorders, chronic obstructive pulmonary disease, arrhythmia, coronary artery disease, congestive heart failure, chronic renal failure, dementia, abnormal preoperative sodium, potassium, or hemoglobin <10 g/dL were excluded. In-hospital and 90-day data were collected. Student's t-test was used to analyze continuous variables and chi-squared test was used for categorical variables. A pre-hoc analysis examining the primary outcome required 607 patients per group to achieve 80% power.
The protocol group included 937 patients, whereas the control group included 891 patients. The protocol group had fewer females and total hip arthroplasties. There were no differences in age, body mass index, American Society of Anesthesiologists classification, tranexamic acid administration, or estimated blood loss between the protocol and control groups. There were also no differences in transfusions, electrolyte corrections, unplanned consults, length of stay, or transfers. The protocol cohort had more fluid boluses and home discharges. There was no difference in 90-day complications between the 2 groups.
This study utilizing an algorithmic approach to laboratory collection demonstrates that discontinuing routine laboratory tests following TJA is safe and effective. We believe this protocol can be implemented for most patients undergoing primary unilateral TJA.
尽管缺乏支持证据,但在全膝关节置换术(TJA)后仍会进行实验室检查。之前没有研究前瞻性分析停止常规实验室检查的效果。本研究旨在确定在 TJA 患者中停止常规实验室检查是否会导致 90 天内并发症的差异。
这是一项在高容量中心进行的前瞻性方案变更研究。在方案变更之前,患者在接受初次单侧 TJA 后进行常规实验室检查(对照组)。在变更后,采用算法方法选择性地订购实验室检查(方案组)。排除有出血性疾病、慢性阻塞性肺疾病、心律失常、冠心病、充血性心力衰竭、慢性肾衰竭、痴呆、术前钠、钾或血红蛋白异常<10 g/dL 的患者。收集住院和 90 天的数据。采用 Student's t 检验分析连续变量,采用卡方检验分析分类变量。一个预先分析检查主要结局需要每组 607 例患者才能达到 80%的效力。
方案组包括 937 例患者,而对照组包括 891 例患者。方案组中女性和全髋关节置换术患者较少。两组在年龄、体重指数、美国麻醉师协会分类、氨甲环酸给药和估计失血量方面无差异。两组在输血、电解质纠正、非计划咨询、住院时间或转科方面也无差异。方案组有更多的液体冲击和出院回家。两组 90 天并发症无差异。
本研究采用算法方法收集实验室数据,表明在 TJA 后停止常规实验室检查是安全有效的。我们认为,这种方案可以应用于大多数接受初次单侧 TJA 的患者。